Extended ‐release naltrexone (XR‐NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry

ConclusionsAmong opioid‐dependent people receiving extended‐release naltrexone treatment, better mental health, higher education, and lower recent drug use at baseline are associated with greater treatment duration; in turn, longer treatment duration is associated with lower relapse rates and improved outcomes generally.

Source: Addiction - March 1, 2018 Category: Addiction Authors: Andrew J. Saxon, Sarah C. Akerman, Chih Chin Liu, Maria A. Sullivan, Bernard L. Silverman, Frank J. Vocci Tags: Research Report Source Type: research